BE ATC L04AB06 · updated 2 Nov 2026
Golimumab shortage in Belgium
Is there a Golimumab shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Golimumab product is reported short in Belgium, the first since 10 Aug 2026. The company estimate for the return is 31 Jan 2027. Main reason: other.
Also short in Germany, Italy, Sweden, Japan. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Simponi 50 mg (Orifarm) inj. sol. s.c. pre-filled pen 0.5 ml | Janssen-Cilag International | 10 Aug 2026 | 31 Jan 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.